Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Benicar
Pharma
Daiichi Sankyo relinquishes rights to 8 cardio drugs to Cosette
In its effort to diversify, Cosette Pharma of New Jersey has acquired the U.S. rights to eight aging cardiovascular drugs from Daiichi Sankyo.
Kevin Dunleavy
Jan 18, 2022 7:35am
Daiichi Sankyo offers $300M to settle 2,300 Benicar lawsuits
Aug 1, 2017 5:25pm
Hey, doc, how about a burger with a side of branded drug scripts?
Jun 21, 2016 7:51am